Brief: Brainsway Announces Extended Private Insurance Coverage In Washington State For The Treatment Of Ocd And Depression Utilizing Deep Tms™
11/01/2023 14:09
Brainsway Ltd BWAY.TA :
* BRAINSWAY ANNOUNCES EXTENDED PRIVATE INSURANCE COVERAGE IN
WASHINGTON STATE FOR THE TREATMENT OF OCD AND DEPRESSION
UTILIZING DEEP TMS™
Source text for Eikon: ID:nGNXcgh5Bf
Further company coverage: BWAY.TA
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)